(Q62110335)
Statements
A Phase IA Trial of Combined Murine IgG Monoclonal Anti-Transferrin Receptor Antibodies E2.3 and A27.15 in Cancer Patients (English)
0 references
December 1997
0 references
February 2001
0 references
27
0 references